STAT Plus: Two years of halting progress and high turnover preceded Atul Gawande’s exit as Haven CEO
Atul Gawande’s announcement last week that he was stepping down as CEO of a high-profile…
Author: STAT
Vaccine experts say Moderna didn’t produce data critical to assessing Covid-19 vaccine
Heavy hearts soared Monday with news that Moderna’s Covid-19 vaccine candidate — the frontrunner in the…
STAT Plus: Amid conflict-of-interest criticisms, top FDA officials recuse themselves from Covid-19 vaccine approvals
A version of this article first appeared in D.C. Diagnosis, STAT’s weekly newsletter about the…
CEO tapped by Trump to make generic drugs during pandemic has a dicey track record
As the chief executive of Phylo, the new company awarded $354 million by the federal government…
FDA, partnering with New York health tech firm, seeks to collect ‘real-world’ data on Covid-19
The Food and Drug Administration said Tuesday that it will launch a new research project…
STAT Plus: Pharmalittle: White House signs deal for U.S.-made generics to fight Covid-19; Gilead expands remdesivir donations
Rise and shine, another brand new day is here. Thanks to a sunny sky and…
STAT Plus: Moderna carries a big-boy market valuation now, so it shouldn’t act like a biotech penny stock
Some additional thoughts and comments on Moderna, its coronavirus vaccine, the stock’s valuation and Monday…
Opinion: Covid-19 has exposed the limits of the pharmaceutical market model
That so much hope is being pinned on remdesivir, the drug Gilead is testing for…
Opinion: Ventilators can save people with serious Covid-19. The people behind them are even more important
In mid-March, the day before I flew back to New York City to return to…
As Covid-19 lockdowns are lifted, uncertainty at nursing homes only deepens
It was late April when a Covid-19 outbreak was reported at the Seven Hills Health…
9 ways Covid-19 may forever upend the U.S. health care industry
WASHINGTON — In the U.S. alone, Covid-19 has claimed nearly 100,000 lives and 30 million…
Gilead ups its donation of the Covid-19 drug remdesivir for U.S. hospitals
Gilead Sciences, the drug company behind the experimental Covid-19 therapy remdesivir, has upped the number…
STAT Plus: Despite skepticism, Gilead’s remdesivir could become a ‘multi-year commercial opportunity’
As speculation mounts over pricing for remdesivir, a Gilead Sciences (GILD) executive suggested the experimental…
STAT Plus: Alexion becomes latest company to face pressure to sell from activist investor
When Elliott Management knocks, it’s difficult not to answer the door. The New York investment firm led…
In combative remarks, Azar tells WHO that its Covid-19 response ‘cost many lives’
WASHINGTON — Health secretary Alex Azar on Monday publicly blasted the World Health Organization, telling…
EMA urged to release full clinical trial data upon authorizing Covid-19 treatments
Amid a worldwide clamor for Covid-19 medicines and vaccines, the European Medicines Agency is being…
STAT Plus: Google develops AI to identify patients at high risk of blindness
Artificial intelligence has shown an increasing ability to detect and diagnose eye diseases by analyzing…
STAT Plus: Pharmalittle: U.K. will get first access to an AstraZeneca Covid-19 vaccine; VA will continue using old malaria drug
Good morning, everyone, and welcome to another working week. We hope the weekend interlude was…
Early data show Moderna Covid-19 vaccine generates immune response
A candidate vaccine for Covid-19 developed by the drug maker Moderna appears to generate an…
Opinion: Hospitals shouldn’t be exempt from reporting faulty radioisotope injections
Medical imaging has experienced tremendous growth since the discovery of X-rays: the x-ray-based CT scanner,…
Opinion: If J&J really wants to support nurses, it should make the TB drug bedaquiline affordable
As nurses who worked in 5B, the first U.S. hospital ward dedicated HIV/AIDS, which opened…
Life as a Covid-19 contact tracer: sleuthing, stress, and veering off-script
All Maddie Bender knew when she called the New Haven, Conn., family was that a…
Utah went all-in on an unproven Covid-19 treatment, then scrambled to course-correct
Even before President Trump started plugging chloroquine and hydroxychloroquine as Covid-19 treatments, enthusiasm for the…
Opinion: A pandemic plan was in place. Trump abandoned it — and science — in the face of Covid-19
President Obama was bothered. It was the summer of 2009 and he was in a…
WHO embraces plan for Covid-19 intellectual property pool
In response to the global race to combat the Covid-19 pandemic, the World Health Organization…
The Trump administration outlines audacious plan to deliver ‘hundreds of millions’ of Covid-19 vaccine doses by end of 2020
WASHINGTON — The Trump administration on Friday rolled out a hyper-ambitious plan to develop and…
STAT Plus: Pharmalittle: France piles pressure on Sanofi over Covid-19 vaccine; GOP fails to land a punch on Bright
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Pfizer says efficacy of its Duchenne gene therapy outweighs side effects
Pfizer’s experimental gene therapy to treat Duchenne muscular dystrophy appeared to improve muscle function in…
FDA says Abbott’s 5-minute Covid-19 test may miss infected patients
The Food and Drug Administration said late Thursday that the Abbott ID Now rapid test…
Opinion: Contact tracing must balance privacy and public health
Contact tracing armies in California and New Jersey. Rapid-response contact tracing in Washington. Track and…
Opinion: Life with an autistic child can be difficult. During a pandemic it can be grueling
The coronavirus pandemic has disrupted daily life for most people around the world. It has…
Opinion: Testing everyone for Covid-19 doesn’t make sense. We need to test smarter, not harder
In response to calls for Covid-19 testing of the entire U.S. population, several large universities,…
Under an ‘America First’ president, will the U.S. corner the market on Covid-19 vaccine?
The United States is sprinting headlong toward the development and distribution of Covid-19 vaccines. But…
Less than a movie ticket or ‘impossible to overpay’? Experts name their price for remdesivir
Two weeks ago, the world learned that remdesivir, a treatment from Gilead Sciences, has a…
STAT Plus: Many pivotal drug studies don’t include data on race or ethnicity, analysis finds
Amid concerns that clinical trials do not adequately represent patient populations, a new analysis finds…
Rick Bright is facing attacks from Republicans across Washington, but his opponents can’t seem to land a punch
WASHINGTON — It may have been Rick Bright’s best day in two months. The ousted…
Listen: Covid-19 in the White House, an audacious approach to Parkinson’s, and the public health lessons from porn
What can the adult film industry teach us about fighting coronavirus? Does the FDA approve…
Trump administration fires back at ousted vaccine expert as he testifies on his role in U.S. coronavirus response
WASHINGTON — The Trump administration accused a federal whistleblower Thursday of “one-sided arguments and misinformation”…
STAT Plus: Pharmalittle: Sanofi walks back Covid-19 vaccine remarks; Trump to name vaccine czar with conflicts
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
Opinion: Is Anthony Fauci today’s Galileo Galilei, the champion of science?
Defending science and scientific integrity can be a frustrating and lonely battle. As I watch…
Biotech’s new chief lobbyist says she’s a social justice advocate. Will the industry walk the walk?
WASHINGTON — Michelle McMurry-Heath doesn’t talk about biotech the way her peers do. Where other…
Opinion: Americans think the government should regulate profits from Covid-19 treatments. Be careful what you wish for
As the death toll from the novel coronavirus climbs toward 90,000, a new national survey…
Opinion: Covid-19, a ‘supernova in human history,’ will need multiple perspectives to understand and manage
Covid-19 is a tragic infection that is killing hundreds of thousands of people around the…
Opinion: Gilead should ditch remdesivir and focus on its simpler and safer ancestor
In the midst of a pandemic like Covid-19, for which there are no FDA-approved drug…
Ethics questions swirl around historic Parkinson’s experiment
A secretive experiment revealed this week, in which neurosurgeons transplanted brain cells into a patient…
CVS long-term care pharmacy pays $15 million penalty for failing to track opioids
Omnicare, which is the largest long-term care pharmacy in the U.S., agreed to pay a…
Cats can catch Covid-19 from one another, study finds. The question is: Can we?
With sporadic reports in recent weeks of cats infected with the coronavirus that causes Covid-19,…
STAT Plus: Amgen’s KRAS-blocking drug shows small improvement in colon cancer response
Amgen’s experimental KRAS-blocking drug is showing a modest improvement in response rates for patients with…
STAT Plus: Roche’s novel checkpoint inhibitor delivers mixed results in new lung cancer study
Roche on Wednesday said a two-drug combination that includes a novel but still experimental checkpoint-blocking…
STAT Plus: Some blood cancer patients see remission with Allogene’s off-the-shelf CAR-T cells, early data show
Allogene on Wednesday released the first data on tumor responses to its off-the-shelf CAR-T cell…